Cochlear Receives FDA Approval for Feature in Nucleus, Baha Systems
Cochlear Limited (ASX: COH) announced that it has obtained Food and Drug Administration (FDA) approval and clearance in the last month for its Cochlear Remote Assist solution in the Nucleus and Baha Systems.
Read More